Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $901,901 - $1.36 Million
-7,700 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $621,005 - $1.01 Million
2,750 Added 55.56%
7,700 $1.96 Million
Q3 2021

Oct 25, 2021

BUY
$221.9 - $484.47 $1.1 Million - $2.4 Million
4,950 New
4,950 $1.91 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $20.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track United Maritime Capital LLC Portfolio

Follow United Maritime Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Maritime Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Maritime Capital LLC with notifications on news.